|
Next Meeting
Preprogram Reception from 5:30 - 6:30 p.m.,
Both
the reception and the academic program will be held in the Sequoia Room
|
||||
|
Tuesday,
June 8, 2010
Summer Slide Seminar: City of Hope
Massimo D'Apuzzo, MD, PhD
Virtual slide images of each case are available for previewing on
www.pathXchange.org from the
LASOP homepage under “Groups.”
• To join PathXchange, visit www.pathxchange.org and create an account.
Once registered, you will receive an email notifying you that your
account is pending approval. After your account has been approved by
administration, you will receive a second email with your account
details, including your one-time password and a link for immediate
access. |
||||
|
Objectives of Program:
1. Develop expertise in the use and limitations of Ki-67 staining in brain tumors. 2. Apply immunohistochemistry in the differential diagnosis of non-lymphoid primary tumors of the spleen. 3. Employ diagnostic tools to diagnose a rare hematopietic stem cell disorder. 4. Use immunohistochemistry to differentiate Merkel cell carcinoma from differential diagnostic considerations and identify the proposed role of polyoma virus in its etiology.
Gap Analysis:
1. Community hospital pathologists are often first line diagnosticians of brain tumors, but may not be aware of newer techniques commonly applied in academic centers in changing standards of reporting prognostic factors. 2. Splenic tumors are rare, but occasionally encountered in general surgical practice, and nonlymphoid tumors are an even rarer subset. A case that demonstrates differential diagnosis and application of immunochemistry is of benefit to developing members' expertise. 3. Primary stem cell disorders are rare. While their diagnosis is usually established in subspecialty environments, recognition of their place in hematopoietic differential diagnosis can help practicing pathologists know when to refer such cases. 4. Merkel cell carcinoma is a highly deadly skin cancer that can easily be missed by pathologists. A society member aware of its diagnostic features and use of immunochemistry could save a life.
Case based presentations, with images offered to the membership prior to the conference as virtual microscopic unknowns posted on PathXchange.org, will be used to develop the participants' expertise in applying diagnostic knowledge and tools.
Identified Need:
Identified by membership as valuable for its
provision of information in the field of Pathology. Accreditation:
The Los Angeles Society of Pathologists, Inc. is accredited by the
Institute for Medical Quality and the California Medical Association to
provide continuing medical education for physicians. The Los Angeles
Society of Pathologists, Inc. takes responsibility for the content,
quality and scientific integrity of this CME activity. |
||||
|
© 2006-2010 Los Angeles Society of Pathologists, Inc. |